Literature DB >> 12810410

Effect of carob bean on gastric emptying time in Thai infants.

Boosba Vivatvakin1, Vacharee Buachum.   

Abstract

Thickening agents, such as carob bean gum or galactomannan, have been successfully administered for the treatment of gastroesophageal reflux in infants. To study the effect of carob bean gum on gastric emptying and to symptoms of regurgitation, we recruited 20 full term Thai infants (mean age=13.4+/-7 week; mean body weight=4943+/-1272gm) without pathological gastroesophageal reflux. Initially, we determined half time gastric emptying (T 1/2 GET) by Tc99m radioscintigraphy method (mean T 1/2 GET=116.1+/-72 min) in infants consuming standard infant cow's milk formula for 2 weeks. Afterwards, carob bean infant formula was given for 2-4 weeks and weight gain, vomiting symptoms, night cough, colic, flatus, defaecation character and T 1/2 GET were assessed. There were statistically significant improvements in symptoms of vomiting (a smaller quantity P<0.001 and frequency of vomiting P<0.0001) and improvements in weight gain per week (W1=121.2+106.9gm, W2=221.3+136.1gm; P=0.005) when infants consumed the carob bean formula. However, there was no significance difference in gastric emptying half time (GET1=116.1+72, GET2=148.5+130.9; P=0.154). In conclusion, carob bean gum, as a thickening agent, improves the clinical symptoms of regurgitating infants, but does not significantly alter the gastric emptying physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810410

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  3 in total

1.  Effects of carob-bean gum thickened formulas on infants' reflux and tolerance indices.

Authors:  Miglena Georgieva; Yannis Manios; Niya Rasheva; Ruzha Pancheva; Elena Dimitrova; Anne Schaafsma
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 2.  Functional Components of Carob Fruit: Linking the Chemical and Biological Space.

Authors:  Vlasios Goulas; Evgenios Stylos; Maria V Chatziathanasiadou; Thomas Mavromoustakos; Andreas G Tzakos
Journal:  Int J Mol Sci       Date:  2016-11-10       Impact factor: 5.923

3.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.